Side effects across medicines
Medicines whose labels list ocular hyperemia
31 medicines have an FDA label that names ocular hyperemia in its boxed warning, warnings, adverse reactions, trial table, patient leaflet or Drug Facts “stop use” warning (of the labels PlainMeds reads: each medicine's quoted label and up to eight more, by route and wording). Among them, the most FAERS reports of ocular hyperemia name cyclosporine (2,438), latanoprost (1,320) and cenegermin (1,231), through July 30, 2026. A label lists what its studies and reports found, and a report does not show that a medicine caused the event.
Check it at the source: the FDA FAERS public dashboard; FDA labels on DailyMed.
Which medicines' labels list ocular hyperemia?
Ordered by where the label names it, the boxed warning first, then by FAERS reports. A medicine whose own indications name it, because it treats it, is not counted.
| Medicine | Where a label names it | FAERS reports of ocular hyperemia |
|---|---|---|
| Cyclosporine | adverse reactions (ophthalmic/ | 2,438 |
| Latanoprost | adverse reactions | 1,320 |
| Cenegermin | adverse reactions | 1,231 |
| Brimonidine | adverse reactions | 747 |
| Travoprost | adverse reactions | 495 |
| Ranibizumab | adverse reactions | 453 |
| Aflibercept | adverse reactions | 419 |
| Brimonidine and brinzolamide | adverse reactions | 363 |
| Moxifloxacin | adverse reactions (ophthalmic label) | 306 |
| Aceclidine | adverse reactions | 268 |
| Risperidone | adverse reactions | 107 |
| Isotretinoin | adverse reactions | 90 |
| Nepafenac | adverse reactions | 69 |
| Faricimab | adverse reactions | 66 |
| Ioversol | adverse reactions | 58 |
| Gadoterate | adverse reactions | 53 |
| Gadobenate | adverse reactions | 32 |
| Aflibercept-mrbb | adverse reactions | none in the top 1,000 |
| Benoxinate and fluorescein | adverse reactions | none in the top 1,000 |
| Carbachol | adverse reactions | none in the top 1,000 |
| Cytarabine and daunorubicin | adverse reactions | none in the top 1,000 |
| Desflurane | adverse reactions | none in the top 1,000 |
| Flurbiprofen | adverse reactions | none in the top 1,000 |
| Methylene blue | adverse reactions | none in the top 1,000 |
| Olipudase alfa | adverse reactions | none in the top 1,000 |
| Omidenepag isopropyl | adverse reactions | none in the top 1,000 |
| Paricalcitol | adverse reactions (intravenous label) | none in the top 1,000 |
| Riboflavin 5-phosphate ophthalmic | adverse reactions | none in the top 1,000 |
| Sirolimus | adverse reactions (topical label) | none in the top 1,000 |
| Tisotumab vedotin | adverse reactions | none in the top 1,000 |
| Vardenafil | adverse reactions | none in the top 1,000 |
Source: FDA drug labels via openFDA, read October 8, 2026; FAERS via openFDA, reports through July 30, 2026
Which of them have the most ocular hyperemia reports in FAERS?
Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; MedDRA preferred term “Ocular Hyperaemia”
What next?
- Side effects across medicines
- every reaction on PlainMeds
- Report a side effect to the FDA
- MedWatch